GE HealthCare's (GEHC) New Launch to Enhance Cardiac Care
https://www.zacks.com/stock/news/2250682/ge-healthcare-s-gehc-new-launch-to-enhance-cardiac-care?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2250682
Apr 04, 2024 - GE HealthCare's (GEHC) latest offering is likely to expand access to cardiac care by enabling more medical professionals to be able to capture cardiac images.
0
Glaukos' (GKOS) iDose TR Receives Permanent J- Code From CMS
https://www.zacks.com/stock/news/2250683/glaukos-gkos-idose-tr-receives-permanent-j-code-from-cms?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2250683
Apr 04, 2024 - Glaukos (GKOS) announces the receipt of a permanent J-code for iDose TR from the CMS, which is likely to boost the billing and payment process.
0
Reasons to Add Cardinal Health (CAH) to Your Portfolio Now
https://www.zacks.com/stock/news/2250638/reasons-to-add-cardinal-health-cah-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2250638
Apr 04, 2024 - Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.
0
Here's Why You Should Add Ecolab (ECL) to Your Portfolio Now
https://www.zacks.com/stock/news/2250627/here-s-why-you-should-add-ecolab-ecl-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2250627
Apr 04, 2024 - Ecolab's (ECL) focus on research and development raises optimism about the stock.
0
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
https://www.zacks.com/stock/news/2250299/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2250299
Apr 04, 2024 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
0
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
https://www.zacks.com/stock/news/2249871/reasons-to-retain-pacbio-pacb-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2249871
Apr 03, 2024 - PacBio's (PACB) strong product demand and top-line growth raise optimism about the stock.
0
QuidelOrtho's (QDEL) QuickVue Gets FDA Nod for COVID Testing
https://www.zacks.com/stock/news/2249868/quidelortho-s-qdel-quickvue-gets-fda-nod-for-covid-testing?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2249868
Apr 03, 2024 - QuidelOrtho (QDEL) announces the FDA's approval of QuickVue, which is likely to be used for convenient and accurate COVID-19 pathogen testing.
0
Here's Why Investors Should Buy Alcon (ALC) Stock Right Now
https://www.zacks.com/stock/news/2249788/here-s-why-investors-should-buy-alcon-alc-stock-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2249788
Apr 03, 2024 - Strength in the Surgical and Vision Care businesses bodes well for Alcon (ALC).
0
Here's Why You Should Retain CONMED (CNMD) Stock for Now
https://www.zacks.com/stock/news/2249828/here-s-why-you-should-retain-conmed-cnmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2249828
Apr 03, 2024 - CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
0
Veeva Systems' (VEEV) CFO Resignation Sparks 6% Stock Drop
https://www.zacks.com/stock/news/2249829/veeva-systems-veev-cfo-resignation-sparks-6-stock-drop?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2249829
Apr 03, 2024 - Veeva Systems' (VEEV) CFO, Brent Bowman, steps down, causing a 6% stock price decline. Analysts weigh in on the impact and prospects for the cloud-solutions company.
0